During the most recent trading session, Hologic, Inc. (NASDAQ:HOLX) shares traded -0.34%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $-0.34 off of the 50-day moving average of $43.69 and $2.27 separated from the 200-day moving average of $41.08. Taking a further look from a different perspective, the stock has been recently recorded -5.86% off of the 52-week high of 46.05 and +32.81% apart from the 52-week low of 32.64. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment.
Price Target in Focus
While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now. Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $47.53 on company shares. This is a near-term estimate for the next 12-18 months.
Currently, Hologic, Inc. has a price to earnings ratio of 15.54. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of 2.20.
For the current quarter, analysts are expecting Rowan Companies plc (NYSE:RDC) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Rowan Companies plc (NYSE:RDC) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of N/A%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Rowan Companies plc (NYSE:RDC) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Rowan Companies plc (NYSE:RDC) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.
The Wall Street analysts who cover Mobileye N.V. (NYSE:MBLY) shares are providing price target projections on the company. They project that the shares will move to $N/A within the upcoming year. The number they've arrived at is calculated by Zacks.com, long known as a provider of top-notch investment research. From the analysts polled by Zack's Research, the highest estimate stands at $N/A and the lowest is at $N/A for the stock. This number may be different from what First Call has published for the consensus target estimate. Analysts that routinely cover the company may use varying techniques in order to create a future target price. Because of the different methods that analysts can use, targets may differ greatly between analysts.
Analyst Ratings In View
Zacks provides the average brokerage recommendation (ABR) for thousands of stocks for institutions and retail investors alike. This the calculated average of the actual recommendations (strong buy, hold, sell etc.) made for a given stock. The ABR is typically displayed with decimals (e.g. 1.52) versus the Zacks Rank, which is only shown in whole numbers (e.g. 1, 2, 3, etc.). This simplifies brokerage recommendations, which can become complicated. Mobileye N.V. (NYSE:MBLY)'s shares currently have an ABR of N/A. A 1 rating would point to a Strong Buy, and a score of 5 would signify a Strong Sell rating. The average broker rating assists investors by providing them with a general feel for analyst sentiment on company shares. The success of analyst predictions can be tracked for institutional investors through First Call. Retail investors can use tools such as TipRanks or Marketbeat in order to track analyst performance.
During this fiscal period, Street analysts are projecting $N/A earnings/share. This represents the current Zacks consensus EPS. For the period which closed on N/A, Mobileye N.V. (NYSE:MBLY) dialed in an EPS of $N/A, creating a Surprise Factor of N/A% (the difference between analyst projections and actual numbers). Curious investors will be awaiting N/A, the date when Mobileye N.V. (NYSE:MBLY) will release their quarterly results. A surprise factor in either direction may result in significant stock movement immediately and in the days following the release. Firms that consistently miss expectations can experience a downtrend over time. Whereas stocks that consistently outperform analyst expectations, can often see positive stock movement.